Nervgen Pharma (NGEN) Assets Average (2026)
Nervgen Pharma (NGEN) posted quarterly Assets Average of $15.9 million for Q1 2026.
Nervgen Pharma (NGEN) Assets Average (2026) Analysis & Trends
Nervgen Pharma (NGEN) has reported Assets Average for 1 consecutive years, with $15.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average changed N/A year-over-year to $15.9 million; the TTM figure through Mar 2026 stood at $15.9 million (changed N/A YoY), while the FY2025 annual figure was $15.3 million, changed N/A from the prior year.
- Assets Average held at $15.9 million in Q1 2026 per NGEN's latest filing.
- Across five years, Assets Average topped out at $15.9 million in Q1 2026 and bottomed at $15.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Nervgen Pharma | 161.78 Mn | 161.78 Mn | - | 40.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.89 Mn |